No single marker has been shown to be sufficient to confer stem-cell-like properties, thus a combination of different markers is used to identify and isolate CSC in glioma, including Nestin, Sox2 (SRY-related HMG-box gene 2) and Musashi-1 (Msi-1). This evidence concerns the gene MSI1 and central nervous system cancer.